Biogen Ends Clinical Trial
In December 2019, Don was examined by 5 neurologists and 2 neuropsychologists who had observed him over the past year. All said they couldn’t believe he was the same man they had seen before. The changes have been remarkable. Two days later, we were notified that his trial was terminated.
It took us time to realize that Biogen had halted another trial utilizing BIIB092 because it didn’t meet its endpoint goals, but the data from the TAUBasket trial had NOT been evaluated.
Page 9 of 10